Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 17 | 2022 | 299 | 3.500 |
Why?
|
| Knee Joint | 12 | 2022 | 577 | 1.960 |
Why?
|
| Osteoarthritis, Hip | 7 | 2019 | 88 | 1.920 |
Why?
|
| Vibration | 8 | 2018 | 27 | 1.670 |
Why?
|
| Shoes | 6 | 2019 | 31 | 1.470 |
Why?
|
| Gait | 13 | 2019 | 386 | 1.370 |
Why?
|
| Weight-Bearing | 12 | 2018 | 138 | 1.240 |
Why?
|
| Pain | 8 | 2022 | 347 | 1.210 |
Why?
|
| Muscle Strength | 5 | 2016 | 102 | 1.190 |
Why?
|
| Osteoarthritis | 7 | 2018 | 294 | 1.120 |
Why?
|
| Pain Measurement | 6 | 2018 | 428 | 0.840 |
Why?
|
| Proprioception | 3 | 2014 | 18 | 0.790 |
Why?
|
| Walking | 5 | 2019 | 235 | 0.760 |
Why?
|
| Leg | 3 | 2008 | 41 | 0.730 |
Why?
|
| Biomechanical Phenomena | 11 | 2019 | 555 | 0.680 |
Why?
|
| Rheumatology | 4 | 2022 | 77 | 0.640 |
Why?
|
| Middle Aged | 24 | 2019 | 8096 | 0.630 |
Why?
|
| Orthotic Devices | 3 | 2010 | 25 | 0.610 |
Why?
|
| Female | 30 | 2022 | 13305 | 0.600 |
Why?
|
| Male | 25 | 2019 | 12823 | 0.540 |
Why?
|
| Hyperalgesia | 1 | 2018 | 46 | 0.540 |
Why?
|
| Humans | 38 | 2022 | 23495 | 0.540 |
Why?
|
| Pain Management | 3 | 2010 | 132 | 0.520 |
Why?
|
| Sensation | 1 | 2016 | 11 | 0.500 |
Why?
|
| Somatosensory Disorders | 2 | 2018 | 10 | 0.500 |
Why?
|
| Joint Instability | 2 | 2016 | 325 | 0.480 |
Why?
|
| Disease Progression | 7 | 2018 | 550 | 0.470 |
Why?
|
| Exercise Therapy | 4 | 2022 | 85 | 0.450 |
Why?
|
| Aged | 15 | 2019 | 7709 | 0.430 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2020 | 252 | 0.390 |
Why?
|
| Foot Orthoses | 1 | 2013 | 12 | 0.390 |
Why?
|
| Range of Motion, Articular | 5 | 2018 | 604 | 0.350 |
Why?
|
| Touch | 2 | 2008 | 8 | 0.340 |
Why?
|
| Bone Density | 1 | 2011 | 146 | 0.320 |
Why?
|
| Joints | 2 | 2008 | 67 | 0.320 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 84 | 0.320 |
Why?
|
| Sensory Thresholds | 4 | 2012 | 21 | 0.320 |
Why?
|
| Pressure | 3 | 2019 | 52 | 0.270 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 807 | 0.230 |
Why?
|
| Foot | 2 | 2016 | 41 | 0.230 |
Why?
|
| Hip Joint | 3 | 2019 | 387 | 0.220 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 171 | 0.220 |
Why?
|
| Musculoskeletal Development | 1 | 2003 | 2 | 0.200 |
Why?
|
| Quadriceps Muscle | 2 | 2016 | 27 | 0.200 |
Why?
|
| Radiography | 2 | 2018 | 547 | 0.200 |
Why?
|
| Pilot Projects | 4 | 2017 | 369 | 0.200 |
Why?
|
| Knee | 2 | 2016 | 38 | 0.200 |
Why?
|
| Adult | 12 | 2019 | 7090 | 0.180 |
Why?
|
| Rheumatologists | 2 | 2020 | 14 | 0.180 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 68 | 0.180 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2003 | 120 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 163 | 0.170 |
Why?
|
| Feedback, Sensory | 1 | 2019 | 9 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2022 | 1500 | 0.150 |
Why?
|
| Smartphone | 1 | 2019 | 14 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 696 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2022 | 197 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 783 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 109 | 0.130 |
Why?
|
| Absorptiometry, Photon | 2 | 2022 | 86 | 0.130 |
Why?
|
| Phototherapy | 1 | 2017 | 26 | 0.120 |
Why?
|
| Fibromyalgia | 1 | 2017 | 27 | 0.120 |
Why?
|
| Risk Factors | 5 | 2016 | 2026 | 0.120 |
Why?
|
| Touch Perception | 1 | 2016 | 2 | 0.120 |
Why?
|
| Aging | 1 | 2003 | 1180 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 561 | 0.120 |
Why?
|
| Mechanical Phenomena | 1 | 2016 | 21 | 0.120 |
Why?
|
| Feedback | 1 | 2016 | 33 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2016 | 31 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 369 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2016 | 106 | 0.110 |
Why?
|
| Incidence | 1 | 2016 | 642 | 0.110 |
Why?
|
| Quality of Life | 2 | 2022 | 570 | 0.090 |
Why?
|
| Sensation Disorders | 1 | 2012 | 9 | 0.090 |
Why?
|
| Femoracetabular Impingement | 1 | 2016 | 223 | 0.090 |
Why?
|
| Perception | 1 | 2012 | 66 | 0.090 |
Why?
|
| Menisci, Tibial | 1 | 2012 | 98 | 0.080 |
Why?
|
| Braces | 1 | 2010 | 20 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2012 | 227 | 0.080 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 143 | 0.080 |
Why?
|
| Demography | 1 | 2010 | 60 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 303 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2012 | 163 | 0.080 |
Why?
|
| Income | 1 | 2010 | 67 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2012 | 239 | 0.070 |
Why?
|
| Exercise | 1 | 2012 | 404 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 204 | 0.070 |
Why?
|
| Extremities | 1 | 2008 | 24 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3058 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 3874 | 0.060 |
Why?
|
| Body Height | 1 | 2006 | 31 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 129 | 0.060 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2006 | 374 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 17 | 0.060 |
Why?
|
| Methotrexate | 1 | 2005 | 36 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 146 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 402 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 26 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2022 | 28 | 0.040 |
Why?
|
| Etanercept | 1 | 2002 | 21 | 0.040 |
Why?
|
| Teaching | 1 | 2022 | 46 | 0.040 |
Why?
|
| Physical Examination | 1 | 2022 | 94 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 121 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2022 | 191 | 0.040 |
Why?
|
| Rotation | 1 | 2019 | 116 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 1724 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 32 | 0.040 |
Why?
|
| Reoperation | 1 | 2002 | 767 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 128 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 87 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2003 | 827 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 445 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2017 | 25 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 89 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 608 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 210 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 212 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1276 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1106 | 0.020 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2012 | 13 | 0.020 |
Why?
|
| Weight Lifting | 1 | 2012 | 8 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2012 | 35 | 0.020 |
Why?
|
| Denmark | 1 | 2012 | 9 | 0.020 |
Why?
|
| Sweden | 1 | 2012 | 7 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 1528 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 126 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 203 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 507 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2010 | 9 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 71 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 552 | 0.020 |
Why?
|
| Arthroscopy | 1 | 2016 | 742 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 269 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 223 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 315 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 95 | 0.010 |
Why?
|